Evolent Health Stock Price, News & Analysis (NYSE:EVH)

$15.05 0.45 (3.08 %)
(As of 01/16/2018 06:43 AM ET)
Previous Close$14.60
Today's Range$14.40 - $15.10
52-Week Range$10.30 - $27.50
Volume1.50 million shs
Average Volume1.20 million shs
Market Capitalization$1.16 billion
P/E Ratio-13.32
Dividend YieldN/A
Beta1.07

About Evolent Health (NYSE:EVH)

Evolent Health logoEvolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryN/A
SectorComputer and Technology
SymbolNYSE:EVH
CUSIPN/A
Phone571-389-6000

Debt

Debt-to-Equity Ratio0.11%
Current Ratio3.34%
Quick Ratio3.34%

Price-To-Earnings

Trailing P/E Ratio-13.3185840707965
Forward P/E Ratio-26.40
P/E GrowthN/A

Sales & Book Value

Annual Sales$254.19 million
Price / Sales4.58
Cash Flow$1.77 per share
Price / Cash8.50
Book Value$13.43 per share
Price / Book1.12

Profitability

Trailing EPS($1.13)
Net Income$-159,740,000.00
Net Margins-15.86%
Return on Equity-5.05%
Return on Assets-3.96%

Miscellaneous

Employees2,400
Outstanding Shares77,340,000

Evolent Health (NYSE:EVH) Frequently Asked Questions

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health Inc (NYSE:EVH) announced its quarterly earnings results on Thursday, November, 2nd. The technology company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.04. The technology company earned $107.90 million during the quarter, compared to analyst estimates of $104.49 million. Evolent Health had a negative return on equity of 5.05% and a negative net margin of 15.86%. The firm's revenue was up 79.2% on a year-over-year basis. During the same quarter last year, the firm posted ($0.26) earnings per share. View Evolent Health's Earnings History.

Where is Evolent Health's stock going? Where will Evolent Health's stock price be in 2018?

13 Wall Street analysts have issued 1 year price targets for Evolent Health's stock. Their predictions range from $23.00 to $32.00. On average, they expect Evolent Health's stock price to reach $28.00 in the next year. View Analyst Ratings for Evolent Health.

What are Wall Street analysts saying about Evolent Health stock?

Here are some recent quotes from research analysts about Evolent Health stock:

  • 1. Cantor Fitzgerald analysts commented, "Health plan acquisitions. Over the past few months, EVH has announced two small health plan acquisitions that should help to grow its platform and operations revenue and add a new line of business. The acquisition of Premier in Dayton, OH, is somewhat more concerning for investors as the regulatory filings show that the plan is in a loss position. However, many provider-owned health plans typically show losses in regulatory filings. The company is expecting to receive better pricing from Premier and that it is not considering additional health plan acquisitions, at least in the near term. However, it will continue to use capital to align the company with customers. Note, our estimates do not yet reflect the health plan acquisitions." (12/3/2017)
  • 2. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (10/9/2017)

Are investors shorting Evolent Health?

Evolent Health saw a increase in short interest during the month of December. As of December 15th, there was short interest totalling 16,038,670 shares, an increase of 26.5% from the November 30th total of 12,678,910 shares. Based on an average daily volume of 2,040,799 shares, the days-to-cover ratio is presently 7.9 days. Currently, 24.9% of the shares of the stock are sold short.

Who are some of Evolent Health's key competitors?

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:

  • Seth Blackley, President (Age 36)
  • Frank John Williams, Chief Executive Officer, Director (Age 50)
  • Nicholas P. McGrane, Chief Financial Officer (Age 48)
  • Thomas Peterson III, Chief Operating Officer (Age 45)
  • Charles W. Pomeroy Jr., Chief Technology Officer (Age 49)
  • Lydia Stone, Principal Accounting Officer, Corporate Controller (Age 40)
  • Jonathan D. Weinberg, General Counsel (Age 50)
  • Dave Thornton, Chief Talent Officer (Age 40)
  • Steven J. Wigginton, Chief Development Officer (Age 49)
  • Bridget Duffy, Director

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who owns Evolent Health stock?

Evolent Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include UNITEDHEALTH GROUP INC (7.70%). Company insiders that own Evolent Health stock include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Michael D'amato, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc and Upmc. View Institutional Ownership Trends for Evolent Health.

How do I buy Evolent Health stock?

Shares of Evolent Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of Evolent Health stock can currently be purchased for approximately $15.05.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $1.16 billion and generates $254.19 million in revenue each year. The technology company earns $-159,740,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis. Evolent Health employs 2,400 workers across the globe.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.


MarketBeat Community Rating for Evolent Health (EVH)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  268 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  380
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Evolent Health (NYSE:EVH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.083.08
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $28.00$28.00$28.45$30.10
Price Target Upside: 108.96% upside117.90% upside56.77% upside19.44% upside

Evolent Health (NYSE:EVH) Consensus Price Target History

Price Target History for Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2018CitigroupInitiated CoverageBuyHighView Rating Details
12/3/2017Cantor FitzgeraldReiterated RatingBuy$30.00LowView Rating Details
11/18/2017Leerink SwannSet Price TargetBuy$25.00N/AView Rating Details
11/7/2017Goldman Sachs GroupDowngradeConviction-Buy -> BuyN/AView Rating Details
11/3/2017SunTrust BanksReiterated RatingBuy$30.00N/AView Rating Details
11/1/2017Robert W. BairdReiterated RatingBuy$25.00N/AView Rating Details
10/6/2017Canaccord GenuityReiterated RatingBuy$32.00N/AView Rating Details
10/6/2017CowenReiterated RatingOutperform$33.00 -> $29.00N/AView Rating Details
9/19/2017KeyCorpInitiated CoverageOverweight -> Overweight$23.00LowView Rating Details
9/6/2017Jefferies GroupReiterated RatingBuy$28.00LowView Rating Details
8/18/2017JPMorgan Chase & Co.Reiterated RatingBuyLowView Rating Details
3/14/2017CIBCInitiated CoverageOutperform -> OutperformLowView Rating Details
3/13/2017OppenheimerInitiated CoverageOutperform$28.00LowView Rating Details
1/13/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformN/AView Rating Details
9/30/2016William BlairReiterated RatingOutperformN/AView Rating Details
8/5/2016FBR & CoBoost Price TargetOutperform$24.00 -> $26.00N/AView Rating Details
(Data available from 1/16/2016 forward)

Earnings

Evolent Health (NYSE:EVH) Earnings History and Estimates Chart

Earnings by Quarter for Evolent Health (NYSE:EVH)

Evolent Health (NYSE EVH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017Q3 2017($0.08)($0.04)$104.49 million$107.90 millionViewN/AView Earnings Details
8/7/2017Q2 2017($0.13)($0.13)$104.45 million$107.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.26)$104.38 million$106.80 millionViewListenView Earnings Details
2/28/2017Q416($0.20)($0.35)$84.98 million$88.00 millionViewListenView Earnings Details
11/9/2016Q316($0.13)($0.26)$58.35 million$60.20 millionViewListenView Earnings Details
8/4/2016Q216($0.16)($0.12)$51.96 million$56.50 millionViewN/AView Earnings Details
5/12/2016Q116($0.19)($0.16)$47.40 million$49.50 millionViewListenView Earnings Details
2/25/2016Q415($0.21)($0.05)$43.73 million$46.70 millionViewListenView Earnings Details
11/5/2015Q315($0.21)($0.16)$42.51 million$43.30 millionViewN/AView Earnings Details
8/6/2015Q215($0.37)($1.00)$157.50 million$36.50 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Evolent Health (NYSE:EVH) Earnings Estimates

2018 EPS Consensus Estimate: ($0.05)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184($0.05)($0.02)($0.03)
Q2 20183($0.01)$0.01$0.00
Q3 20183($0.01)($0.01)($0.01)
Q4 20183($0.01)$0.01$0.00
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Evolent Health (NYSE:EVH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Evolent Health (NYSE EVH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.79%
Institutional Ownership Percentage: 95.38%
Insider Trades by Quarter for Evolent Health (NYSE:EVH)
Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Evolent Health (NYSE EVH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2017Frank J. WilliamsCEOSell16,300$23.73$386,799.00View SEC Filing  
8/1/2017Steve WiggintonCEOSell6,000$24.64$147,840.00View SEC Filing  
7/24/2017Thomas Peterson IIICOOSell40,540$26.00$1,054,040.00View SEC Filing  
7/10/2017Nicholas McgraneCFOSell1,667$25.42$42,375.14View SEC Filing  
7/6/2017Frank J. WilliamsCEOSell16,300$24.76$403,588.00View SEC Filing  
7/3/2017Steve WiggintonCEOSell6,000$25.07$150,420.00View SEC Filing  
6/28/2017Tpg Growth Ii Advisors, Inc.InsiderSell4,279,325$25.87$110,706,137.75View SEC Filing  
6/15/2017Seth BlackleyPresidentSell15,000$25.22$378,300.00View SEC Filing  
6/12/2017Nicholas McgraneCFOSell1,667$24.58$40,974.86View SEC Filing  
6/7/2017Nicholas McgraneCFOSell10,495$26.95$282,840.25View SEC Filing  
6/6/2017Kenneth A. SametDirectorSell4,000$25.75$103,000.00View SEC Filing  
6/6/2017Steve WiggintonCEOSell959$25.75$24,694.25View SEC Filing  
5/19/2017Cheryl ScottDirectorSell5,477$23.51$128,764.27View SEC Filing  
5/19/2017Frank J. WilliamsCEOSell114,865$24.30$2,791,219.50View SEC Filing  
5/19/2017Jonathan WeinbergGeneral CounselSell17,230$24.30$418,689.00View SEC Filing  
5/19/2017Nicholas McgraneCFOSell47,508$24.30$1,154,444.40View SEC Filing  
5/19/2017Thomas Peterson IIICOOSell57,433$24.30$1,395,621.90View SEC Filing  
5/19/2017Tpg Growth Ii Advisors, Inc.InsiderSell3,081,760$24.30$74,886,768.00View SEC Filing  
5/19/2017UpmcMajor ShareholderSell2,333,333$24.30$56,699,991.906,434,283View SEC Filing  
5/15/2017Seth BlackleyPresidentSell15,000$25.00$375,000.00760,944View SEC Filing  
5/15/2017Thomas Peterson IIICOOSell83,108$24.99$2,076,868.92341,092View SEC Filing  
5/10/2017Nicholas McgraneInsiderSell1,667$24.28$40,474.76132,047View SEC Filing  
5/10/2017Thomas Peterson IIICOOSell18,604$25.00$465,100.00395,587View SEC Filing  
5/4/2017Frank J WilliamsCEOSell16,300$23.55$383,865.001,284,943View SEC Filing  
5/3/2017Jonathan WeinbergGeneral CounselSell15,000$23.85$357,750.0086,385View SEC Filing  
5/1/2017Steve WiggintonCEOSell6,000$23.10$138,600.00364,704View SEC Filing  
5/1/2017UpmcMajor ShareholderSell403,644$19.53$7,883,167.328,767,616View SEC Filing  
4/19/2017Nicholas McgraneCFOSell1,667$22.52$37,540.84132,047View SEC Filing  
4/17/2017Seth BlackleyPresidentSell15,000$21.48$322,200.00794,602View SEC Filing  
4/6/2017Frank J WilliamsCEOSell16,300$22.03$359,089.001,301,243View SEC Filing  
4/3/2017Steve WiggintonCEOSell6,000$23.15$138,900.00364,704View SEC Filing  
3/31/2017UpmcMajor ShareholderSell2,690,961$19.53$52,554,468.339,171,260View SEC Filing  
3/30/2017Seth BlackleyPresidentSell15,000$21.19$317,850.00807,228View SEC Filing  
3/28/2017Board Co AdvisoryMajor ShareholderSell2,118,078$19.53$41,366,063.346,246,245View SEC Filing  
3/24/2017Nicholas McgraneCFOSell7,034$22.50$158,265.00137,414View SEC Filing  
1/30/2017Seth BlackleyPresidentSell15,000$17.58$263,700.00824,848View SEC Filing  
1/17/2017Seth BlackleyPresidentSell30,000$17.98$539,400.00854,848View SEC Filing  
11/14/2016Michael D'amatoDirectorBuy10,000$17.18$171,800.0018,183View SEC Filing  
9/22/2016Board Co AdvisoryMajor ShareholderSell317,712$22.50$7,148,520.004,128,167View SEC Filing  
9/14/2016Board Co AdvisoryMajor ShareholderSell1,936,529$22.50$43,571,902.504,445,879View SEC Filing  
9/14/2016Chad PomeroyInsiderSell55,180$21.54$1,188,577.20286,370View SEC Filing  
9/14/2016Frank J WilliamsCEOSell251,481$21.54$5,416,900.741,304,799View SEC Filing  
9/14/2016Jonathan WeinbergGeneral CounselSell10,339$21.54$222,702.0676,245View SEC Filing  
9/14/2016Nicholas McgraneCFOSell21,205$21.54$456,755.70136,495View SEC Filing  
9/14/2016Seth BlackleyPresidentSell167,672$21.54$3,611,654.88869,848View SEC Filing  
9/14/2016Thomas Peterson IIICOOSell72,827$21.54$1,568,693.58377,623View SEC Filing  
6/10/2015Gary PieferInsiderBuy2,000$17.00$34,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Evolent Health (NYSE EVH) News Headlines

Source:
DateHeadline
William Blair Comments on Evolent Health Incs FY2019 Earnings (EVH)William Blair Comments on Evolent Health Inc's FY2019 Earnings (EVH)
www.americanbankingnews.com - January 15 at 3:44 PM
KeyCorp Comments on Evolent Health Incs Q1 2018 Earnings (EVH)KeyCorp Comments on Evolent Health Inc's Q1 2018 Earnings (EVH)
www.americanbankingnews.com - January 15 at 5:38 AM
Evolent Health Inc to Post Q4 2018 Earnings of ($0.01) Per Share, KeyCorp Forecasts (EVH)Evolent Health Inc to Post Q4 2018 Earnings of ($0.01) Per Share, KeyCorp Forecasts (EVH)
www.americanbankingnews.com - January 12 at 8:02 PM
Brokers Offer Predictions for Evolent Health Incs FY2017 Earnings (EVH)Brokers Offer Predictions for Evolent Health Inc's FY2017 Earnings (EVH)
www.americanbankingnews.com - January 8 at 2:28 AM
Evolent Health Inc Forecasted to Post Q3 2018 Earnings of ($0.01) Per Share (EVH)Evolent Health Inc Forecasted to Post Q3 2018 Earnings of ($0.01) Per Share (EVH)
www.americanbankingnews.com - January 5 at 12:32 PM
Evolent Health Sees Unusually Large Options Volume (EVH)Evolent Health Sees Unusually Large Options Volume (EVH)
www.americanbankingnews.com - January 5 at 2:10 AM
Complete Genomics (GNOM) & Evolent Health (EVH) Financial ComparisonComplete Genomics (GNOM) & Evolent Health (EVH) Financial Comparison
www.americanbankingnews.com - January 4 at 5:04 PM
Evolent Health Completes Acquisition of Assets from New Mexico ... - PR Newswire (press release)Evolent Health Completes Acquisition of Assets from New Mexico ... - PR Newswire (press release)
www.prnewswire.com - January 2 at 11:27 PM
Evolent Health Completes Acquisition of Assets from New Mexico Health ConnectionsEvolent Health Completes Acquisition of Assets from New Mexico Health Connections
finance.yahoo.com - January 2 at 6:27 PM
Evolent Health Inc (EVH) Given Average Recommendation of "Buy" by AnalystsEvolent Health Inc (EVH) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - January 2 at 9:58 AM
Evolent Health Inc (EVH) Short Interest Up 26.5% in DecemberEvolent Health Inc (EVH) Short Interest Up 26.5% in December
www.americanbankingnews.com - January 2 at 4:50 AM
Evolent Health Inc (EVH) Expected to Post Quarterly Sales of $111.21 MillionEvolent Health Inc (EVH) Expected to Post Quarterly Sales of $111.21 Million
www.americanbankingnews.com - December 31 at 10:28 AM
Analyzing Cotiviti (COTV) and Evolent Health (EVH)Analyzing Cotiviti (COTV) and Evolent Health (EVH)
www.americanbankingnews.com - December 30 at 3:28 AM
Evolent Health, Inc. – Value Analysis (NYSE:EVH) : December 29, 2017Evolent Health, Inc. – Value Analysis (NYSE:EVH) : December 29, 2017
finance.yahoo.com - December 29 at 5:05 PM
Evolent Health, Inc. breached its 50 day moving average in a Bearish Manner : EVH-US : December 28, 2017Evolent Health, Inc. breached its 50 day moving average in a Bearish Manner : EVH-US : December 28, 2017
finance.yahoo.com - December 28 at 8:19 AM
Evolent Health (EVH) vs. Cotiviti (COTV) Head-To-Head ComparisonEvolent Health (EVH) vs. Cotiviti (COTV) Head-To-Head Comparison
www.americanbankingnews.com - December 27 at 1:20 PM
Analyzing Evolent Health (EVH) and Press Ganey (PGND)Analyzing Evolent Health (EVH) and Press Ganey (PGND)
www.americanbankingnews.com - December 25 at 3:54 PM
ETFs with exposure to Evolent Health, Inc. : December 18, 2017ETFs with exposure to Evolent Health, Inc. : December 18, 2017
finance.yahoo.com - December 18 at 5:09 PM
SunTrust Banks Weighs in on Evolent Health Incs FY2017 Earnings (EVH)SunTrust Banks Weighs in on Evolent Health Inc's FY2017 Earnings (EVH)
www.americanbankingnews.com - December 15 at 7:52 AM
Evolent Health Inc Forecasted to Post Q1 2018 Earnings of ($0.02) Per Share (EVH)Evolent Health Inc Forecasted to Post Q1 2018 Earnings of ($0.02) Per Share (EVH)
www.americanbankingnews.com - December 14 at 11:04 AM
Evolent Health Inc (EVH) Expected to Post Earnings of -$0.04 Per ShareEvolent Health Inc (EVH) Expected to Post Earnings of -$0.04 Per Share
www.americanbankingnews.com - December 12 at 1:34 AM
Premier Health, Virginia company terminate sale of insurance businessPremier Health, Virginia company terminate sale of insurance business
finance.yahoo.com - December 11 at 5:21 PM
Critical Contrast: Press Ganey (PGND) versus Evolent Health (EVH)Critical Contrast: Press Ganey (PGND) versus Evolent Health (EVH)
www.americanbankingnews.com - December 9 at 1:48 AM
Pre-Open Movers 12/08: (STDY) (SIGM) (ALXN) Higher; (AOBC) (TELL) (LJPC) Lower (more...)Pre-Open Movers 12/08: (STDY) (SIGM) (ALXN) Higher; (AOBC) (TELL) (LJPC) Lower (more...)
www.streetinsider.com - December 8 at 5:05 PM
Evolent Health drops acquisition deal with Ohio companyEvolent Health drops acquisition deal with Ohio company
finance.yahoo.com - December 8 at 5:05 PM
Evolent Health Inc (EVH) Given Consensus Recommendation of "Buy" by AnalystsEvolent Health Inc (EVH) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - December 8 at 9:52 AM
Evolent Health and Premier Health Announce Termination of Agreement for Acquisition of Premier Health PlanEvolent Health and Premier Health Announce Termination of Agreement for Acquisition of Premier Health Plan
finance.yahoo.com - December 8 at 9:39 AM
Analysis of Industry Group Rank Make Evolent Health (EVH) a SellAnalysis of Industry Group Rank Make Evolent Health (EVH) a Sell
investorplace.com - December 7 at 3:56 PM
Cantor Fitzgerald Reaffirms "Buy" Rating for Evolent Health (EVH)Cantor Fitzgerald Reaffirms "Buy" Rating for Evolent Health (EVH)
www.americanbankingnews.com - December 3 at 12:44 PM
Evolent Health Inc (EVH) Sees Significant Decrease in Short InterestEvolent Health Inc (EVH) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - November 29 at 3:10 AM
ETFs with exposure to Evolent Health, Inc. : November 27, 2017ETFs with exposure to Evolent Health, Inc. : November 27, 2017
finance.yahoo.com - November 27 at 5:53 PM
Zacks: Analysts Anticipate Evolent Health Inc (EVH) Will Post Quarterly Sales of $111.21 MillionZacks: Analysts Anticipate Evolent Health Inc (EVH) Will Post Quarterly Sales of $111.21 Million
www.americanbankingnews.com - November 26 at 12:32 PM
Alan Fournier"s 8 Largest Sales of the 3rd QuarterAlan Fournier"s 8 Largest Sales of the 3rd Quarter
finance.yahoo.com - November 22 at 7:09 PM
Evolent Health, Inc (EVH) Given a $25.00 Price Target at Leerink SwannEvolent Health, Inc (EVH) Given a $25.00 Price Target at Leerink Swann
www.americanbankingnews.com - November 19 at 7:48 AM
Evolent Health (EVH) a Sell on Sagging Earnings Momentum ... - Investorplace.comEvolent Health (EVH) a Sell on Sagging Earnings Momentum ... - Investorplace.com
investorplace.com - November 17 at 5:16 PM
Evolent Health, Inc. :EVH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 15, 2017Evolent Health, Inc. :EVH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 15, 2017
finance.yahoo.com - November 16 at 7:08 PM
Evolent Health (EVH) a Sell on Sagging Earnings MomentumEvolent Health (EVH) a Sell on Sagging Earnings Momentum
investorplace.com - November 16 at 2:57 PM
ETFs with exposure to Evolent Health, Inc. : November 16, 2017ETFs with exposure to Evolent Health, Inc. : November 16, 2017
finance.yahoo.com - November 16 at 2:05 PM
Evolent Health to Participate in Upcoming Investor ConferenceEvolent Health to Participate in Upcoming Investor Conference
finance.yahoo.com - November 14 at 6:53 PM
Evolent Health, Inc (EVH) Receives Average Recommendation of "Buy" from BrokeragesEvolent Health, Inc (EVH) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - November 13 at 10:26 AM
Earnings Growth Make Evolent Health (EVH) a Sell - Investorplace.comEarnings Growth Make Evolent Health (EVH) a Sell - Investorplace.com
investorplace.com - November 10 at 2:20 PM
Earnings Growth Make Evolent Health (EVH) a SellEarnings Growth Make Evolent Health (EVH) a Sell
investorplace.com - November 9 at 6:24 PM
Bloomberg Markets: Dave Wilson’s Chart of the Day for Nov. 6Bloomberg Markets: Dave Wilson’s Chart of the Day for Nov. 6
www.bloomberg.com - November 6 at 8:04 PM
 Brokerages Expect Evolent Health, Inc (EVH) to Post -$0.05 EPS Brokerages Expect Evolent Health, Inc (EVH) to Post -$0.05 EPS
www.americanbankingnews.com - November 5 at 1:08 AM
Relative Strength Alert For Evolent HealthRelative Strength Alert For Evolent Health
www.thestreet.com - November 4 at 11:38 PM
Evolent Health, Inc (EVH) Rating Reiterated by SunTrust Banks, Inc.Evolent Health, Inc (EVH) Rating Reiterated by SunTrust Banks, Inc.
www.americanbankingnews.com - November 4 at 10:12 AM
Evolent Health, Inc (EVH) Announces Quarterly  Earnings Results, Beats Expectations By $0.04 EPSEvolent Health, Inc (EVH) Announces Quarterly Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - November 3 at 5:48 PM
Evolent Health Announces Third Quarter 2017 Results - PR Newswire (press release)Evolent Health Announces Third Quarter 2017 Results - PR Newswire (press release)
www.prnewswire.com - November 3 at 12:40 PM
Edited Transcript of EVH earnings conference call or presentation 2-Nov-17 9:00pm GMTEdited Transcript of EVH earnings conference call or presentation 2-Nov-17 9:00pm GMT
finance.yahoo.com - November 3 at 12:40 PM
Evolent Healths (EVH) "Buy" Rating Reiterated at Cantor FitzgeraldEvolent Health's (EVH) "Buy" Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - November 2 at 10:30 PM

SEC Filings

Evolent Health (NYSE:EVH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Evolent Health (NYSE:EVH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Evolent Health (NYSE EVH) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.